nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—CYP2C19—prostate cancer	0.131	0.611	CbGaD
Olanzapine—CYP3A4—prostate cancer	0.0835	0.389	CbGaD
Olanzapine—ORM1—Abiraterone—prostate cancer	0.067	0.124	CbGbCtD
Olanzapine—ALB—Abiraterone—prostate cancer	0.0282	0.0523	CbGbCtD
Olanzapine—CYP2C19—Bicalutamide—prostate cancer	0.022	0.0409	CbGbCtD
Olanzapine—CYP2C19—Nilutamide—prostate cancer	0.022	0.0409	CbGbCtD
Olanzapine—ALB—Estrone—prostate cancer	0.0204	0.0378	CbGbCtD
Olanzapine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0203	0.0377	CbGbCtD
Olanzapine—CYP2C9—Bicalutamide—prostate cancer	0.0183	0.034	CbGbCtD
Olanzapine—CYP2C9—Nilutamide—prostate cancer	0.0183	0.034	CbGbCtD
Olanzapine—CYP2C19—Flutamide—prostate cancer	0.0183	0.0339	CbGbCtD
Olanzapine—CYP1A2—Flutamide—prostate cancer	0.0169	0.0313	CbGbCtD
Olanzapine—CYP2D6—Bicalutamide—prostate cancer	0.0168	0.0311	CbGbCtD
Olanzapine—ABCB1—Estramustine—prostate cancer	0.0165	0.0307	CbGbCtD
Olanzapine—CYP2D6—Abiraterone—prostate cancer	0.0139	0.0258	CbGbCtD
Olanzapine—ADRA1B—vas deferens—prostate cancer	0.0139	0.173	CbGeAlD
Olanzapine—CYP1A2—Estrone—prostate cancer	0.0122	0.0226	CbGbCtD
Olanzapine—ALB—Estradiol—prostate cancer	0.0117	0.0217	CbGbCtD
Olanzapine—CYP2C9—Estrone—prostate cancer	0.011	0.0204	CbGbCtD
Olanzapine—ABCB1—Cabazitaxel—prostate cancer	0.0109	0.0202	CbGbCtD
Olanzapine—CYP3A4—Bicalutamide—prostate cancer	0.0107	0.0198	CbGbCtD
Olanzapine—ABCB1—Estrone—prostate cancer	0.0107	0.0198	CbGbCtD
Olanzapine—ALB—Prednisone—prostate cancer	0.0101	0.0187	CbGbCtD
Olanzapine—CYP3A4—Estramustine—prostate cancer	0.00991	0.0184	CbGbCtD
Olanzapine—ABCB1—Ethinyl Estradiol—prostate cancer	0.0095	0.0176	CbGbCtD
Olanzapine—CYP3A4—Flutamide—prostate cancer	0.00883	0.0164	CbGbCtD
Olanzapine—CYP3A4—Abiraterone—prostate cancer	0.00883	0.0164	CbGbCtD
Olanzapine—CYP2C9—Capecitabine—prostate cancer	0.00832	0.0155	CbGbCtD
Olanzapine—HTR7—vas deferens—prostate cancer	0.00809	0.101	CbGeAlD
Olanzapine—CYP1A2—Conjugated Estrogens—prostate cancer	0.00797	0.0148	CbGbCtD
Olanzapine—CYP2C19—Estradiol—prostate cancer	0.00759	0.0141	CbGbCtD
Olanzapine—CYP1A2—Estradiol—prostate cancer	0.007	0.013	CbGbCtD
Olanzapine—ABCB1—Conjugated Estrogens—prostate cancer	0.00697	0.0129	CbGbCtD
Olanzapine—CYP3A4—Cabazitaxel—prostate cancer	0.00653	0.0121	CbGbCtD
Olanzapine—CYP2C19—Prednisone—prostate cancer	0.00652	0.0121	CbGbCtD
Olanzapine—CHRM3—ureter—prostate cancer	0.00651	0.0811	CbGeAlD
Olanzapine—CYP3A4—Estrone—prostate cancer	0.00639	0.0119	CbGbCtD
Olanzapine—ABCB1—Mitoxantrone—prostate cancer	0.00634	0.0118	CbGbCtD
Olanzapine—CYP2C9—Estradiol—prostate cancer	0.00631	0.0117	CbGbCtD
Olanzapine—ABCB1—Estradiol—prostate cancer	0.00612	0.0114	CbGbCtD
Olanzapine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00569	0.0106	CbGbCtD
Olanzapine—ABCB1—Prednisone—prostate cancer	0.00526	0.00977	CbGbCtD
Olanzapine—H1F0—semen—prostate cancer	0.00467	0.0582	CbGeAlD
Olanzapine—CYP1A2—Etoposide—prostate cancer	0.00457	0.00849	CbGbCtD
Olanzapine—FMO3—urine—prostate cancer	0.00445	0.0554	CbGeAlD
Olanzapine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00418	0.00776	CbGbCtD
Olanzapine—ABCB1—Etoposide—prostate cancer	0.004	0.00742	CbGbCtD
Olanzapine—CYP3A4—Mitoxantrone—prostate cancer	0.0038	0.00705	CbGbCtD
Olanzapine—CYP3A4—Estradiol—prostate cancer	0.00367	0.00681	CbGbCtD
Olanzapine—ABCB1—Docetaxel—prostate cancer	0.00366	0.00679	CbGbCtD
Olanzapine—CYP3A4—Prednisone—prostate cancer	0.00315	0.00586	CbGbCtD
Olanzapine—ABCB1—Doxorubicin—prostate cancer	0.00273	0.00506	CbGbCtD
Olanzapine—CYP2D6—Doxorubicin—prostate cancer	0.00257	0.00477	CbGbCtD
Olanzapine—CYP3A4—Etoposide—prostate cancer	0.00239	0.00445	CbGbCtD
Olanzapine—CYP3A4—Docetaxel—prostate cancer	0.00219	0.00407	CbGbCtD
Olanzapine—CYP2C19—urine—prostate cancer	0.00197	0.0245	CbGeAlD
Olanzapine—HRH4—bone marrow—prostate cancer	0.00174	0.0217	CbGeAlD
Olanzapine—CYP3A4—Doxorubicin—prostate cancer	0.00163	0.00303	CbGbCtD
Olanzapine—CYP1A2—urine—prostate cancer	0.00161	0.02	CbGeAlD
Olanzapine—FMO3—prostate gland—prostate cancer	0.0016	0.0199	CbGeAlD
Olanzapine—CYP2C9—urine—prostate cancer	0.00152	0.019	CbGeAlD
Olanzapine—HTR2A—urine—prostate cancer	0.00125	0.0156	CbGeAlD
Olanzapine—H1F0—prostate gland—prostate cancer	0.00117	0.0146	CbGeAlD
Olanzapine—CYP3A4—urine—prostate cancer	0.00116	0.0145	CbGeAlD
Olanzapine—CYP2D6—urine—prostate cancer	0.00114	0.0143	CbGeAlD
Olanzapine—DRD4—testis—prostate cancer	0.00101	0.0126	CbGeAlD
Olanzapine—ORM1—prostate gland—prostate cancer	0.000999	0.0125	CbGeAlD
Olanzapine—CHRM5—epithelium—prostate cancer	0.000997	0.0124	CbGeAlD
Olanzapine—H1F0—seminal vesicle—prostate cancer	0.00099	0.0123	CbGeAlD
Olanzapine—CHRM2—prostate gland—prostate cancer	0.000932	0.0116	CbGeAlD
Olanzapine—CHRM1—prostate gland—prostate cancer	0.000848	0.0106	CbGeAlD
Olanzapine—ADRA1B—renal system—prostate cancer	0.000845	0.0105	CbGeAlD
Olanzapine—H1F0—renal system—prostate cancer	0.000798	0.00995	CbGeAlD
Olanzapine—H1F0—urethra—prostate cancer	0.000784	0.00977	CbGeAlD
Olanzapine—CHRM4—testis—prostate cancer	0.000765	0.00954	CbGeAlD
Olanzapine—CHRM3—prostate gland—prostate cancer	0.000759	0.00946	CbGeAlD
Olanzapine—FMO3—testis—prostate cancer	0.000703	0.00877	CbGeAlD
Olanzapine—ADRA1A—prostate gland—prostate cancer	0.000697	0.00869	CbGeAlD
Olanzapine—ADRA2C—prostate gland—prostate cancer	0.000664	0.00828	CbGeAlD
Olanzapine—H1F0—bone marrow—prostate cancer	0.000603	0.00752	CbGeAlD
Olanzapine—ADRA2C—seminal vesicle—prostate cancer	0.000562	0.007	CbGeAlD
Olanzapine—HRH1—prostate gland—prostate cancer	0.000539	0.00672	CbGeAlD
Olanzapine—HTR7—epithelium—prostate cancer	0.000531	0.00662	CbGeAlD
Olanzapine—ADRA2A—prostate gland—prostate cancer	0.00053	0.00661	CbGeAlD
Olanzapine—CHRM3—renal system—prostate cancer	0.000517	0.00645	CbGeAlD
Olanzapine—H1F0—testis—prostate cancer	0.000516	0.00643	CbGeAlD
Olanzapine—HTR1A—renal system—prostate cancer	0.000515	0.00642	CbGeAlD
Olanzapine—ORM1—bone marrow—prostate cancer	0.000515	0.00642	CbGeAlD
Olanzapine—ADRA1A—epithelium—prostate cancer	0.000512	0.00638	CbGeAlD
Olanzapine—FMO3—lymph node—prostate cancer	0.00051	0.00636	CbGeAlD
Olanzapine—CHRM3—urethra—prostate cancer	0.000508	0.00634	CbGeAlD
Olanzapine—HTR7—renal system—prostate cancer	0.000492	0.00614	CbGeAlD
Olanzapine—ADRA1A—renal system—prostate cancer	0.000475	0.00592	CbGeAlD
Olanzapine—HRH2—lymph node—prostate cancer	0.000454	0.00566	CbGeAlD
Olanzapine—ADRA2C—renal system—prostate cancer	0.000453	0.00564	CbGeAlD
Olanzapine—ADRA2A—seminal vesicle—prostate cancer	0.000448	0.00559	CbGeAlD
Olanzapine—ADRA2C—urethra—prostate cancer	0.000445	0.00554	CbGeAlD
Olanzapine—HRH1—epithelium—prostate cancer	0.000396	0.00494	CbGeAlD
Olanzapine—CYP1A2—renal system—prostate cancer	0.000393	0.0049	CbGeAlD
Olanzapine—ALB—testis—prostate cancer	0.000386	0.00481	CbGeAlD
Olanzapine—H1F0—lymph node—prostate cancer	0.000374	0.00466	CbGeAlD
Olanzapine—HRH1—urethra—prostate cancer	0.000361	0.0045	CbGeAlD
Olanzapine—ADRA2A—urethra—prostate cancer	0.000355	0.00442	CbGeAlD
Olanzapine—CHRM3—testis—prostate cancer	0.000334	0.00417	CbGeAlD
Olanzapine—HTR2A—epithelium—prostate cancer	0.000331	0.00413	CbGeAlD
Olanzapine—ORM1—lymph node—prostate cancer	0.000319	0.00398	CbGeAlD
Olanzapine—HTR7—testis—prostate cancer	0.000318	0.00397	CbGeAlD
Olanzapine—HTR2A—renal system—prostate cancer	0.000307	0.00383	CbGeAlD
Olanzapine—DRD2—testis—prostate cancer	0.000301	0.00375	CbGeAlD
Olanzapine—ABCB1—prostate gland—prostate cancer	0.000295	0.00368	CbGeAlD
Olanzapine—ADRA2C—testis—prostate cancer	0.000293	0.00365	CbGeAlD
Olanzapine—CYP3A4—renal system—prostate cancer	0.000284	0.00354	CbGeAlD
Olanzapine—ALB—lymph node—prostate cancer	0.00028	0.00349	CbGeAlD
Olanzapine—CYP2D6—renal system—prostate cancer	0.00028	0.00349	CbGeAlD
Olanzapine—HTR2B—lymph node—prostate cancer	0.000269	0.00336	CbGeAlD
Olanzapine—ABCB1—seminal vesicle—prostate cancer	0.00025	0.00311	CbGeAlD
Olanzapine—HRH1—testis—prostate cancer	0.000238	0.00296	CbGeAlD
Olanzapine—ADRA2A—testis—prostate cancer	0.000233	0.00291	CbGeAlD
Olanzapine—ABCB1—epithelium—prostate cancer	0.000217	0.0027	CbGeAlD
Olanzapine—ADRA2C—lymph node—prostate cancer	0.000212	0.00264	CbGeAlD
Olanzapine—ABCB1—renal system—prostate cancer	0.000201	0.00251	CbGeAlD
Olanzapine—HTR2A—testis—prostate cancer	0.000198	0.00247	CbGeAlD
Olanzapine—ABCB1—urethra—prostate cancer	0.000198	0.00246	CbGeAlD
Olanzapine—Clozapine—CYP1B1—prostate cancer	0.000191	0.175	CrCbGaD
Olanzapine—CYP2D6—testis—prostate cancer	0.000181	0.00225	CbGeAlD
Olanzapine—Quetiapine—CYP3A5—prostate cancer	0.000176	0.162	CrCbGaD
Olanzapine—HRH1—lymph node—prostate cancer	0.000172	0.00215	CbGeAlD
Olanzapine—ADRA2A—lymph node—prostate cancer	0.000169	0.00211	CbGeAlD
Olanzapine—ABCB1—bone marrow—prostate cancer	0.000152	0.0019	CbGeAlD
Olanzapine—Clozapine—CYP2A6—prostate cancer	0.000147	0.135	CrCbGaD
Olanzapine—ABCB1—testis—prostate cancer	0.00013	0.00162	CbGeAlD
Olanzapine—Quetiapine—CYP2C19—prostate cancer	0.00012	0.111	CrCbGaD
Olanzapine—Clozapine—CYP2E1—prostate cancer	0.000104	0.096	CrCbGaD
Olanzapine—Clozapine—CYP2C19—prostate cancer	0.000103	0.0951	CrCbGaD
Olanzapine—Clozapine—CYP1A1—prostate cancer	0.000103	0.0947	CrCbGaD
Olanzapine—ABCB1—lymph node—prostate cancer	9.43e-05	0.00118	CbGeAlD
Olanzapine—Quetiapine—CYP3A4—prostate cancer	7.64e-05	0.0703	CrCbGaD
Olanzapine—Clozapine—CYP3A4—prostate cancer	6.57e-05	0.0605	CrCbGaD
Olanzapine—CHRM2—Signaling Pathways—PTEN—prostate cancer	1.06e-06	6.41e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CDKN1A—prostate cancer	1.06e-06	6.4e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—PTEN—prostate cancer	1.06e-06	6.39e-06	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR downstream signaling—AKT1—prostate cancer	1.05e-06	6.38e-06	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—IL6—prostate cancer	1.05e-06	6.37e-06	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—IL6—prostate cancer	1.05e-06	6.37e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—AKT1—prostate cancer	1.05e-06	6.37e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—EGFR—prostate cancer	1.05e-06	6.36e-06	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—TP53—prostate cancer	1.05e-06	6.36e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—AKT1—prostate cancer	1.05e-06	6.35e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—AKT1—prostate cancer	1.05e-06	6.33e-06	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—IL6—prostate cancer	1.05e-06	6.33e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—EP300—prostate cancer	1.05e-06	6.32e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CASP3—prostate cancer	1.04e-06	6.32e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—AKT1—prostate cancer	1.04e-06	6.31e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IL2—prostate cancer	1.04e-06	6.31e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—NOS3—prostate cancer	1.04e-06	6.31e-06	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—TP53—prostate cancer	1.04e-06	6.29e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—IL6—prostate cancer	1.04e-06	6.28e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MYC—prostate cancer	1.04e-06	6.28e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TGFB1—prostate cancer	1.04e-06	6.26e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—AKT1—prostate cancer	1.03e-06	6.25e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MYC—prostate cancer	1.03e-06	6.24e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—AKT1—prostate cancer	1.03e-06	6.23e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TGFB1—prostate cancer	1.03e-06	6.23e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—TYMS—prostate cancer	1.03e-06	6.22e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—EP300—prostate cancer	1.03e-06	6.22e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—EP300—prostate cancer	1.03e-06	6.21e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.03e-06	6.21e-06	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—PIK3CA—prostate cancer	1.02e-06	6.2e-06	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—IL6—prostate cancer	1.02e-06	6.19e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—EP300—prostate cancer	1.02e-06	6.19e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—EP300—prostate cancer	1.02e-06	6.17e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—PIK3CA—prostate cancer	1.02e-06	6.17e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—NOS3—prostate cancer	1.02e-06	6.15e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GSTM1—prostate cancer	1.02e-06	6.15e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CCND1—prostate cancer	1.02e-06	6.15e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—SRC—prostate cancer	1.02e-06	6.15e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.02e-06	6.14e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—EGFR—prostate cancer	1.02e-06	6.14e-06	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—PIK3CA—prostate cancer	1.01e-06	6.11e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—EP300—prostate cancer	1.01e-06	6.11e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—EGFR—prostate cancer	1.01e-06	6.11e-06	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—IL6—prostate cancer	1.01e-06	6.09e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—EP300—prostate cancer	1.01e-06	6.09e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CTNNB1—prostate cancer	1.01e-06	6.09e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.01e-06	6.09e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MYC—prostate cancer	1e-06	6.07e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TGFB1—prostate cancer	1e-06	6.06e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—SRC—prostate cancer	1e-06	6.05e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—LPL—prostate cancer	9.98e-07	6.04e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—SRC—prostate cancer	9.98e-07	6.04e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—SRC—prostate cancer	9.95e-07	6.02e-06	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—IL6—prostate cancer	9.94e-07	6.01e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—KRAS—prostate cancer	9.93e-07	6.01e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—SRC—prostate cancer	9.92e-07	6e-06	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—TP53—prostate cancer	9.91e-07	5.99e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—VEGFA—prostate cancer	9.9e-07	5.99e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MYC—prostate cancer	9.88e-07	5.98e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MMP9—prostate cancer	9.87e-07	5.97e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TGFB1—prostate cancer	9.86e-07	5.96e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CDKN1A—prostate cancer	9.84e-07	5.95e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—SRC—prostate cancer	9.82e-07	5.94e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—EGFR—prostate cancer	9.82e-07	5.94e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—PTEN—prostate cancer	9.81e-07	5.94e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—STAT3—prostate cancer	9.81e-07	5.93e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—SRC—prostate cancer	9.8e-07	5.92e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CG—prostate cancer	9.79e-07	5.92e-06	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—TP53—prostate cancer	9.78e-07	5.91e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—VEGFA—prostate cancer	9.74e-07	5.89e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—VEGFA—prostate cancer	9.72e-07	5.88e-06	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—AKT1—prostate cancer	9.72e-07	5.88e-06	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—AKT1—prostate cancer	9.71e-07	5.87e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—VEGFA—prostate cancer	9.69e-07	5.86e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—EGFR—prostate cancer	9.67e-07	5.85e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—VEGFA—prostate cancer	9.66e-07	5.84e-06	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—AKT1—prostate cancer	9.65e-07	5.84e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—STAT3—prostate cancer	9.65e-07	5.84e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CYP1A1—prostate cancer	9.64e-07	5.83e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—STAT3—prostate cancer	9.63e-07	5.82e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PIK3CB—prostate cancer	9.62e-07	5.82e-06	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—IL6—prostate cancer	9.62e-07	5.82e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—STAT3—prostate cancer	9.6e-07	5.8e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—NOS3—prostate cancer	9.59e-07	5.8e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—KRAS—prostate cancer	9.59e-07	5.8e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—AKT1—prostate cancer	9.57e-07	5.79e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—VEGFA—prostate cancer	9.57e-07	5.79e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—STAT3—prostate cancer	9.57e-07	5.79e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ERCC2—prostate cancer	9.56e-07	5.78e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—VEGFA—prostate cancer	9.54e-07	5.77e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—KRAS—prostate cancer	9.54e-07	5.77e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PTGS2—prostate cancer	9.54e-07	5.77e-06	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—IL6—prostate cancer	9.52e-07	5.76e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—NOS3—prostate cancer	9.51e-07	5.75e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—STAT3—prostate cancer	9.47e-07	5.73e-06	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—AKT1—prostate cancer	9.45e-07	5.71e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—STAT3—prostate cancer	9.45e-07	5.71e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PIK3CB—prostate cancer	9.39e-07	5.68e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—EP300—prostate cancer	9.36e-07	5.66e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PTGS2—prostate cancer	9.31e-07	5.63e-06	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—AKT1—prostate cancer	9.3e-07	5.62e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—KRAS—prostate cancer	9.28e-07	5.61e-06	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PTEN—prostate cancer	9.26e-07	5.6e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—INS—prostate cancer	9.26e-07	5.6e-06	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—AKT1—prostate cancer	9.17e-07	5.55e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—KRAS—prostate cancer	9.13e-07	5.52e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—PIK3CA—prostate cancer	9.13e-07	5.52e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MYC—prostate cancer	9.11e-07	5.51e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—SRC—prostate cancer	9.1e-07	5.5e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TGFB1—prostate cancer	9.09e-07	5.5e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—CREBBP—prostate cancer	9.07e-07	5.49e-06	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—IL6—prostate cancer	9.07e-07	5.49e-06	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—PIK3CA—prostate cancer	9.02e-07	5.46e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—MTHFR—prostate cancer	8.99e-07	5.44e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MYC—prostate cancer	8.97e-07	5.42e-06	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—IL6—prostate cancer	8.95e-07	5.41e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MYC—prostate cancer	8.95e-07	5.41e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TGFB1—prostate cancer	8.94e-07	5.41e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TGFB1—prostate cancer	8.92e-07	5.4e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MYC—prostate cancer	8.92e-07	5.39e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—EGFR—prostate cancer	8.91e-07	5.39e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TGFB1—prostate cancer	8.9e-07	5.38e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MYC—prostate cancer	8.89e-07	5.38e-06	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—AKT1—prostate cancer	8.87e-07	5.37e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TGFB1—prostate cancer	8.87e-07	5.36e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—VEGFA—prostate cancer	8.86e-07	5.36e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PIK3CB—prostate cancer	8.85e-07	5.35e-06	CbGpPWpGaD
Olanzapine—ALB—Metabolism—EP300—prostate cancer	8.83e-07	5.34e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—TP53—prostate cancer	8.83e-07	5.34e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PPARA—prostate cancer	8.82e-07	5.33e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—PIK3CA—prostate cancer	8.81e-07	5.33e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MYC—prostate cancer	8.8e-07	5.32e-06	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—AKT1—prostate cancer	8.78e-07	5.31e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TGFB1—prostate cancer	8.78e-07	5.31e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MYC—prostate cancer	8.78e-07	5.31e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—STAT3—prostate cancer	8.78e-07	5.31e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PIK3CB—prostate cancer	8.77e-07	5.31e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PTGS2—prostate cancer	8.77e-07	5.3e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—EGFR—prostate cancer	8.77e-07	5.3e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—PIK3CA—prostate cancer	8.76e-07	5.3e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TGFB1—prostate cancer	8.76e-07	5.3e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—EGFR—prostate cancer	8.75e-07	5.29e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—EGFR—prostate cancer	8.72e-07	5.28e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PTGS2—prostate cancer	8.69e-07	5.26e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—EGFR—prostate cancer	8.69e-07	5.26e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—EGFR—prostate cancer	8.61e-07	5.21e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CD—prostate cancer	8.6e-07	5.2e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—EGFR—prostate cancer	8.59e-07	5.19e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—PIK3CA—prostate cancer	8.52e-07	5.16e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TP53—prostate cancer	8.52e-07	5.15e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TP53—prostate cancer	8.48e-07	5.13e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—KRAS—prostate cancer	8.42e-07	5.09e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—PIK3CA—prostate cancer	8.39e-07	5.07e-06	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—AKT1—prostate cancer	8.37e-07	5.06e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—AKT1—prostate cancer	8.33e-07	5.04e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PTEN—prostate cancer	8.32e-07	5.03e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CAV1—prostate cancer	8.29e-07	5.01e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—KRAS—prostate cancer	8.28e-07	5.01e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—PIK3CA—prostate cancer	8.28e-07	5.01e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—KRAS—prostate cancer	8.27e-07	5e-06	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—AKT1—prostate cancer	8.26e-07	4.99e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TP53—prostate cancer	8.25e-07	4.99e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—KRAS—prostate cancer	8.24e-07	4.98e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—KRAS—prostate cancer	8.21e-07	4.97e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MYC—prostate cancer	8.16e-07	4.93e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TGFB1—prostate cancer	8.14e-07	4.92e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—KRAS—prostate cancer	8.13e-07	4.92e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—NOS3—prostate cancer	8.12e-07	4.91e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PTEN—prostate cancer	8.12e-07	4.91e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TP53—prostate cancer	8.12e-07	4.91e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—KRAS—prostate cancer	8.11e-07	4.91e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—IL6—prostate cancer	8.08e-07	4.89e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—EGFR—prostate cancer	7.98e-07	4.83e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—EP300—prostate cancer	7.93e-07	4.8e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—IL6—prostate cancer	7.8e-07	4.72e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—IL6—prostate cancer	7.76e-07	4.69e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—EP300—prostate cancer	7.74e-07	4.68e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—PIK3CA—prostate cancer	7.73e-07	4.68e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PTEN—prostate cancer	7.65e-07	4.63e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—PIK3CA—prostate cancer	7.61e-07	4.6e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—PIK3CA—prostate cancer	7.59e-07	4.59e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PTEN—prostate cancer	7.58e-07	4.59e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—PIK3CA—prostate cancer	7.57e-07	4.58e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CG—prostate cancer	7.55e-07	4.57e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—IL6—prostate cancer	7.55e-07	4.57e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—PIK3CA—prostate cancer	7.55e-07	4.56e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—KRAS—prostate cancer	7.54e-07	4.56e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CB—prostate cancer	7.5e-07	4.54e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TP53—prostate cancer	7.48e-07	4.53e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—PIK3CA—prostate cancer	7.47e-07	4.52e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—AKT1—prostate cancer	7.46e-07	4.51e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—PIK3CA—prostate cancer	7.45e-07	4.51e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PTGS2—prostate cancer	7.43e-07	4.49e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—IL6—prostate cancer	7.43e-07	4.49e-06	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—AKT1—prostate cancer	7.37e-07	4.46e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TP53—prostate cancer	7.36e-07	4.45e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TP53—prostate cancer	7.35e-07	4.44e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TP53—prostate cancer	7.32e-07	4.43e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TP53—prostate cancer	7.3e-07	4.42e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—EP300—prostate cancer	7.29e-07	4.41e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—EP300—prostate cancer	7.23e-07	4.37e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TP53—prostate cancer	7.23e-07	4.37e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TP53—prostate cancer	7.21e-07	4.36e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—AKT1—prostate cancer	7.2e-07	4.35e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—AKT1—prostate cancer	7.16e-07	4.33e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—INS—prostate cancer	7.15e-07	4.32e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CREBBP—prostate cancer	7e-07	4.24e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—AKT1—prostate cancer	6.96e-07	4.21e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—PIK3CA—prostate cancer	6.92e-07	4.19e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—AKT1—prostate cancer	6.85e-07	4.15e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—IL6—prostate cancer	6.85e-07	4.14e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—AKT1—prostate cancer	6.76e-07	4.09e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—IL6—prostate cancer	6.74e-07	4.08e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—IL6—prostate cancer	6.72e-07	4.07e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—IL6—prostate cancer	6.7e-07	4.05e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TP53—prostate cancer	6.7e-07	4.05e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—IL6—prostate cancer	6.68e-07	4.04e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CD—prostate cancer	6.64e-07	4.02e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—IL6—prostate cancer	6.62e-07	4e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—IL6—prostate cancer	6.6e-07	3.99e-06	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PIK3CA—prostate cancer	6.54e-07	3.95e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PTEN—prostate cancer	6.48e-07	3.92e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—AKT1—prostate cancer	6.32e-07	3.82e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—NOS3—prostate cancer	6.27e-07	3.79e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—AKT1—prostate cancer	6.22e-07	3.76e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—AKT1—prostate cancer	6.2e-07	3.75e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—AKT1—prostate cancer	6.18e-07	3.74e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—EP300—prostate cancer	6.18e-07	3.74e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—AKT1—prostate cancer	6.16e-07	3.73e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IL6—prostate cancer	6.13e-07	3.71e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—AKT1—prostate cancer	6.1e-07	3.69e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—AKT1—prostate cancer	6.09e-07	3.68e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PIK3CA—prostate cancer	5.87e-07	3.55e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CB—prostate cancer	5.79e-07	3.5e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PTGS2—prostate cancer	5.73e-07	3.47e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PIK3CA—prostate cancer	5.73e-07	3.46e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—AKT1—prostate cancer	5.66e-07	3.42e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PIK3CA—prostate cancer	5.4e-07	3.26e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PIK3CA—prostate cancer	5.35e-07	3.24e-06	CbGpPWpGaD
Olanzapine—ALB—Metabolism—AKT1—prostate cancer	5.34e-07	3.23e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PTEN—prostate cancer	5e-07	3.02e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—AKT1—prostate cancer	4.79e-07	2.9e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—EP300—prostate cancer	4.77e-07	2.88e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—AKT1—prostate cancer	4.68e-07	2.83e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CA—prostate cancer	4.57e-07	2.76e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—AKT1—prostate cancer	4.41e-07	2.67e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—AKT1—prostate cancer	4.37e-07	2.64e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—AKT1—prostate cancer	3.73e-07	2.26e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CA—prostate cancer	3.53e-07	2.13e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—AKT1—prostate cancer	2.88e-07	1.74e-06	CbGpPWpGaD
